Caprock Group, Inc. Dexcom Inc Transaction History

Caprock Group, Inc.

$4.51 Billion
Q4 2025

A detailed history of Caprock Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Caprock Group, Inc. holds 10,557 shares of DXCM stock, worth $612,939. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,557

Holding current value

$612,939

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 28, 2026	BUY	$54.84 - $71.06 $578,945 - $750,180	10,557 New	10,557 $612,000
Q1 2025 May 15, 2025	SELL	$67.74 - $90.75 $134,192 - $179,775	-1,981 Reduced 30.41%	4,534 $309,000
Q4 2024 Jan 23, 2025	BUY	$65.68 - $81.01 $197,828 - $244,002	3,012 Added 85.98%	6,515 $506,000
Q3 2024 Nov 07, 2024	SELL	$64.0 - $116.06 $325,888 - $590,977	-5,092 Reduced 59.24%	3,503 $234,000
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $261,434 - $332,866	2,370 Added 38.07%	8,595 $974,000

Q1 2024 Apr 29, 2024	SELL	$114.22 - $140.1 $1.34 Million - $1.65 Million	-11,768 Reduced 65.4%	6,225 $863,000
Q4 2023 Jan 18, 2024	BUY	$75.49 - $124.16 $28,837 - $47,429	382 Added 2.17%	17,993 $2.23 Million
Q3 2023 Oct 18, 2023	BUY	$86.06 - $137.93 $41,308 - $66,206	480 Added 2.8%	17,611 $1.64 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $57,472 - $66,930	511 Added 3.07%	17,131 $2.2 Million
Q1 2023 Apr 26, 2023	BUY	$104.0 - $122.92 $49,400 - $58,387	475 Added 2.94%	16,620 $1.93 Million
Q4 2022 Jan 23, 2023	BUY	$84.98 - $122.67 $4,588 - $6,624	54 Added 0.34%	16,145 $0
Q3 2022 Nov 07, 2022	BUY	$76.35 - $94.18 $18,705 - $23,074	245 Added 1.55%	16,091 $1.3 Million
Q2 2022 Jul 26, 2022	BUY	$67.99 - $132.89 $818,055 - $1.6 Million	12,032 Added 315.47%	15,846 $1.18 Million
Q1 2022 Apr 12, 2022	BUY	$94.08 - $130.2 $7,150 - $9,895	76 Added 2.03%	3,814 $1.95 Million
Q4 2021 Jan 18, 2022	BUY	$129.87 - $162.82 $14,285 - $17,910	110 Added 3.03%	3,738 $2.01 Million
Q3 2021 Oct 07, 2021	BUY	$106.71 - $143.18 $7,362 - $9,879	69 Added 1.94%	3,628 $1.98 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $2,186 - $2,914	27 Added 0.76%	3,559 $1.52 Million
Q1 2021 Apr 29, 2021	BUY	$84.79 - $104.74 $3,815 - $4,713	45 Added 1.29%	3,532 $1.27 Million
Q4 2020 Jan 29, 2021	SELL	$78.0 - $104.5 $3,432 - $4,598	-44 Reduced 1.25%	3,487 $1.29 Million
Q3 2020 Oct 29, 2020	BUY	$95.51 - $112.95 $19,293 - $22,815	202 Added 6.07%	3,531 $1.46 Million
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $15,356 - $25,808	245 Added 7.94%	3,329 $1.35 Million
Q1 2020 Apr 28, 2020	SELL	$47.79 - $75.63 $42,246 - $66,856	-884 Reduced 22.28%	3,084 $830,000
Q2 2019 Jul 23, 2019	BUY	$27.84 - $38.92 $139 - $194	5 Added 0.13%	3,968 $595,000
Q1 2019 Apr 12, 2019	BUY	$28.07 - $38.18 $252 - $343	9 Added 0.23%	3,963 $472,000
Q4 2017 Jan 17, 2018	BUY	$11.12 - $15.38 $43,968 - $60,812	3,954	3,954 $224,000

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

375M

Call Options Held

6.76M

Put Options Held

7.24M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account